Anti-Cancer Drugs Journal Issues Research Articles in September 2021 Edition
August 16, 2021
August 16, 2021
LONDON, England, Aug. 16 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its September 2021 edition:
Reviews:
* The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type br . . .
Reviews:
* The efficacy and safety of low-dose Apatinib in the management of stage IV luminal-type br . . .
